Simply Solventless Concentrates Third Quarter 2024 Earnings: EPS: CA$0.006 (vs CA$0.001 in 3Q 2023)
Simply Solventless Concentrates (CVE:HASH) Third Quarter 2024 Results
Key Financial Results
- Revenue: CA$4.95m (up 235% from 3Q 2023).
- Net income: CA$424.4k (up by CA$400.0k from 3Q 2023).
- Profit margin: 8.6% (up from 1.7% in 3Q 2023). The increase in margin was driven by higher revenue.
- EPS: CA$0.006 (up from CA$0.001 in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Simply Solventless Concentrates shares are down 3.7% from a week ago.
Risk Analysis
What about risks? Every company has them, and we've spotted 4 warning signs for Simply Solventless Concentrates (of which 2 shouldn't be ignored!) you should know about.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSXV:HASH
Simply Solventless Concentrates
Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.
Adequate balance sheet slight.